Resveratrol-mediated ADAM9 degradation decreases cancer progression and provides synergistic effects in combination with chemotherapy.

Lin, Yu-Sen; Hsieh, Chih-Ying; Kuo, Ting-Ting; Lin, Ching-Chan; Lin, Chen-Yuan; Sher, Yuh-Pyng

Lin, Yu-Sen; Hsieh, Chih-Ying; Kuo, Ting-Ting; Lin, Ching-Chan; Lin, Chen-Yuan; Sher, Yuh-Pyng.

Afiliación

Lin YS; Graduate Institute of Clinical Medical Science, China Medical University Taichung 404, Taiwan.
Hsieh CY; Division of Thoracic Surgery, China Medical University Hospital Taichung 404, Taiwan.
Kuo TT; Center for Molecular Medicine, China Medical University Hospital Taichung 404, Taiwan.
Lin CC; Center for Molecular Medicine, China Medical University Hospital Taichung 404, Taiwan.
Lin CY; Graduate Institute of Clinical Medical Science, China Medical University Taichung 404, Taiwan.
Sher YP; Division of Hematology and Oncology, China Medical University Hospital Taichung 404, Taiwan.

Am J Cancer Res ; 10(11): 3828-3837, 2020.

Article en En | MEDLINE | ID: mdl-33294270

Palabras clave

ADAM9; Resveratrol; metastasis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Am J Cancer Res Año: 2020 Tipo del documento: Article País de afiliación: Taiwán

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google